which of the antidepressent is used in low dose as hypnotic
Now, looking at the options, the correct answer is likely a TCA. Let's say the options include doxepin, which is known for its use in low doses for sleep. The other options might be SSRIs or SNRIs, which aren't typically used as hypnotics. For example, SSRIs like sertraline are more for depression and anxiety, not sedation. SNRIs like venlafaxine also don't have the same sedative effect. Another possibility is mirtazapine, which is a tetracyclic with sedative properties due to its antihistamine action. But doxepin is more classic in this role.
Wait, the question specifies "low dose as hypnotic." Doxepin is approved in low doses (e.g., 6.25 mg) for insomnia, while in higher doses, it's used for depression. That's a key point. So the correct answer would be doxepin. Let me check the distractors. If the options include other antidepressants like paroxetine (SSRI), duloxetine (SNRI), or maybe trazodone, which is also used as a hypnotic. Trazodone is an antidepressant with sedative properties used off-label for sleep. But the question might be pointing towards doxepin specifically. However, trazodone is another possibility. But the low dose aspect is more specific to doxepin. So the correct answer is doxepin. The other options would be incorrect because they don't have the same mechanism or approved use for insomnia. The clinical pearl here is to remember that TCAs like doxepin and trazodone are used for sleep, but doxepin is specifically approved in low doses for that.
**Core Concept**
This question assesses knowledge of antidepressants with sedative properties, particularly those used off-label or at low doses for insomnia. Tricyclic antidepressants (TCAs) and certain tetracyclics (e.g., mirtazapine) have antihistaminergic effects, causing sedation, which makes them useful as hypnotics.
**Why the Correct Answer is Right**
**Doxepin** is a TCA with strong antihistaminergic and anticholinergic activity. At low doses (e.g., 6.25β12.5 mg), it acts as a hypnotic by blocking H1 histamine receptors in the central nervous system, reducing wakefulness. It is FDA-approved in low doses for insomnia and in higher doses for depression. Its sedative effect is distinct from SSRIs/SNRIs, which generally lack hypnotic properties.
**Why Each Wrong Option is Incorrect**
**Option A:** *Sertraline* (SSRI) increases